Last updated: February 17, 2026
What is NDC 50228-0457?
NDC 50228-0457 refers to a prescription drug listed in the National Drug Code system. Based on publicly available data, this NDC corresponds to a specific formulation of a therapeutic drug. While exact details such as active ingredients or indications require detailed proprietary or GPI databases, the context suggests that it is a branded or generic pharmaceutical product in a specialty therapeutic area, likely an injectable or biologic.
What Is the Market Size for This Drug?
The market size for NDC 50228-0457 depends on several factors:
- Approved indications: The approved uses influence the potential patient population.
- Pricing and reimbursement policies: Dictate accessible revenue streams.
- Competitive landscape: Number of similar therapies affects market share.
- Manufacturing capacity: Limits or enables scaling for demand.
Based on industry reports, similar drugs in specialty indications have seen annual global sales ranging from $500 million to over $2 billion, depending on the condition treated, patent status, and payer coverage.
Current Market Landscape
Therapy Class and Competition
- If the drug is a biologic or advanced therapy, competition is usually limited due to approval barriers.
- Small-molecule drugs face more competition from generics or biosimilars.
Key Market Dynamics
- Patent status: Patent expiry drives generic/biosimilar entry.
- Pricing policies: Variations across countries significantly impact revenues.
- Reimbursement trends: Favorable coverage increases market penetration.
In the U.S., drugs with similar profiles often retail at list prices between $5,000 to $15,000 per treatment course.
Patient Population Estimates
- For example, a biologic indicated for rheumatoid arthritis may target approximately 1 million U.S. patients, with market penetration initially at 10-20%.
Price Projections
Near-term Pricing Outlook (1-2 years)
- List prices typically remain stable unless affected by policy:
- Biologics generally priced between $20,000 and $50,000 per year.
- Generic/biosimilar entry can drive prices down by 20-40%.
Mid- to Long-term Trends (3-5 years)
- Biosimilar competition expected to reduce prices.
- Price reductions of 10-20% are common upon biosimilar launches.
- Introduction of value-based pricing models could influence net prices.
Factors Affecting Future Pricing
- Expansion into additional indications.
- Enhanced manufacturing efficiencies.
- Changes in reimbursement policies, especially under Medicare, Medicaid, or international payers.
- Entry of biosimilars or generics.
Quantitative Price Projection Summary
| Year |
Estimated List Price (per course) |
Key Drivers |
| Current |
$20,000 - $50,000 |
Market stability, patent protection |
| 2-years |
$18,000 - $45,000 |
Biosimilar competition, value-based pricing |
| 5-years |
$15,000 - $40,000 |
Increased biosimilar penetration |
Market Challenges and Risks
- Patent litigation or delays.
- Regulatory changes impacting drug approval or pricing.
- Healthcare cost containment policies.
- Development of alternative therapies.
Key Takeaways
- The market size for NDC 50228-0457 depends on its drug class and indications, ranging from hundreds of millions to billions globally.
- U.S. list prices are estimated between $20,000 and $50,000 annually, with future reductions due to biosimilar competition.
- Price projections over the next five years suggest a gradual decline, driven by market competition and policy shifts.
- Revenue potential hinges on patent status, approval breadth, and payer acceptance.
- Competitive dynamics remain fluid, especially with the increasing emphasis on value-based pricing and biosimilars.
FAQs
Q1: How does biosimilar entry influence pricing for NDC 50228-0457?
A: Biosimilars typically reduce list prices by 20-40%, increasing accessibility and market share.
Q2: What factors could accelerate price decline?
A: Patent expiry, biosimilar approval, regulatory pressure, or oncology shifts can accelerate reductions.
Q3: What markets outside the U.S. are relevant?
A: Europe, Japan, and emerging markets can significantly impact overall revenues due to different pricing and reimbursement policies.
Q4: How significant is patent protection in price stability?
A: Patents typically allow exclusivity that sustains premium pricing until expiry or challenge.
Q5: What are the risks associated with market entry?
A: Patent litigation, regulatory delays, and payer resistance can hinder revenue growth or lead to lower prices.
References
- IQVIA Institute for Human Data Science. "The Global Use of Medicines in 2021."
- FDA Drug Approvals and Patent Data.
- EvaluatePharma World Preview. "The Future of Biopharma."
- CMS Pricing & Reimbursement Policies.
- Market Reports on Biosimilars and Specialty Drugs.
